Epigeneres Biotech

Epigeneres Biotech is a leading biotechnology company that focuses on discovering, developing, manufacturing, and commercializing molecular medicines and nutrigenomic formulations for the treatment and prevention of serious medical conditions such as cancer and age-related diseases. Since its establishment in 2008, the company has positioned itself as a pioneer in the field of advanced genetic therapeutics, standing out with its dedication to addressing critical health challenges. Through a strategic collaboration with Singapore-based Tzar Labs, Epigeneres has co-developed a groundbreaking cancer prognostic and diagnostic technology, for which it holds the sole licensee rights in India. This innovative partnership has effectively expanded Epigeneres' technological portfolio, enhancing its capabilities to combat cancer more efficiently. Despite the lack of specific information on industries or headquarters, Epigeneres' overarching mission and collaborations illustrate its strong potential, positioning it as an intriguing prospect for venture capital investment.

Epigeneres Biotech, with its slogan "Advanced Genetic Therapeutics", demonstrates a commitment to pioneering medical solutions, particularly in the realm of cancer treatment and age-related diseases. Through its co-developed cancer prognostic and diagnostic technology and exclusive licensing in India, the company exhibits a strategic approach to advancing its technological portfolio and improving its market presence.